DCLRE1A and cancer: It is well-established that SNM1A is a key mediator of DNA crosslink repair, and that SNM1A deficient cells are sensitive to drugs that induce DNA crosslinks, such as cisplatin.16,37 We observed cancer cell sensitisation when treatment with cisplatin treatment was combined with 19.